secwatch.observer — SEC 8-K summary
======================================

Issuer:     Drugs Made In America Acquisition II Corp. (DMII)
CIK:        0002040475
Form:       8-K
Filed at:   2025-10-02T23:59:59+00:00
Accession:  0001213900-25-095513
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Drugs Made In America Acquisition II closes $500M IPO and $12M private placement
--------------------------------------------------------------------------------

- IPO of 50M units at $10 each grossed $500M; units trade on Nasdaq (DMIIU).
- Private placement of 1.2M units to sponsor and Cantor Fitzgerald raised $12M.
- $500M deposited into trust account; company has 24 months to complete initial business combination.
- Balance sheet: $1.58M cash, $17.5M deferred underwriting liability, $17.2M accumulated deficit.
- Auditor includes going concern qualification due to mandatory liquidation if no business combination within 24 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/0001213900-25-095513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/ea0259662-8k_drugs2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-095513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer